SEC Filing Summary: Amedica Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on January 18, 2017. The report discloses a material event under Item 7.01 (Regulation FD Disclosure) regarding the commencement of a capital raising activity.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the announcement of a securities offering rather than reporting period-end financial results.
Material Changes and Events
- Capital Raise: On January 18, 2017, the Company commenced an underwritten public offering of its common stock and warrants to purchase common stock.
- Registration Basis: The offering is conducted pursuant to an effective shelf registration statement (File No. 333-205545) declared effective by the SEC on July 20, 2015.
- Disclosure: A press release detailing the offering was issued on the same date and is included as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain specific management guidance, financial outlook, or a discussion of risks and contingencies beyond the standard disclosure of the offering commencement. Investors are directed to the press release (Exhibit 99.1) for further details on the offering terms.
Key Facts for Investor Verification
- Verify the specific terms of the underwritten public offering (price, volume, and warrant details) in the referenced press release (Exhibit 99.1).
- Confirm the status of the shelf registration statement (File No. 333-205545) and any remaining capacity.
- Review the Company's most recent 10-K or 10-Q for baseline financial data, as this 8-K contains no financial statements.